CMC Ambroise Paré

Quick facts

Marketed products

• inert tablet
  An inert tablet contains no active pharmaceutical ingredient and produces no pharmacological effect.

Phase 3 pipeline

• CT-P13 · Immunology / Rheumatology
  CT-P13 is a biosimilar of infliximab that binds to tumor necrosis factor-alpha (TNF-α) to reduce inflammatory signaling.

Phase 2 pipeline

• Bronchial fibroscopy · Respiratory
  Bronchial fibroscopy is a diagnostic procedure that uses a flexible tube with a camera and light to visually examine the airways and lungs.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• CMC Ambroise Paré portfolio CI brief
• CMC Ambroise Paré pipeline updates RSS